• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Case series: ulcerative colitis, multiple sclerosis, and interferon-beta 1a.

作者信息

Rodrigues S, Magro F, Soares J, Nunes A C R, Lopes S, Marques M, Rio E, Macedo G

出版信息

Inflamm Bowel Dis. 2010 Dec;16(12):2001-3. doi: 10.1002/ibd.21242.

DOI:10.1002/ibd.21242
PMID:20186933
Abstract
摘要

相似文献

1
Case series: ulcerative colitis, multiple sclerosis, and interferon-beta 1a.病例系列：溃疡性结肠炎、多发性硬化症与干扰素β-1a
Inflamm Bowel Dis. 2010 Dec;16(12):2001-3. doi: 10.1002/ibd.21242.
2
Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferon beta 1a.一名多发性硬化症患者在接受β-1a干扰素治疗后发生溃疡性结肠炎。
World J Gastroenterol. 2007 Jul 14;13(26):3638-40. doi: 10.3748/wjg.v13.i26.3638.
3
Rapid onset of ulcerative colitis after treatment with interferon β1a in a patient with multiple sclerosis.
J Crohns Colitis. 2011 Feb;5(1):75-6. doi: 10.1016/j.crohns.2010.10.007. Epub 2010 Nov 26.
4
Disease modifying treatment in multiple sclerosis.多发性硬化症的疾病修饰治疗
J Neurol Neurosurg Psychiatry. 2001 Dec;71 Suppl 2(Suppl 2):ii20-1. doi: 10.1136/jnnp.71.suppl_2.ii20.
5
Suppression of inflammation in ulcerative colitis by interferon-β-1a is accompanied by inhibition of IL-13 production.干扰素-β-1a 抑制溃疡性结肠炎的炎症反应伴随着抑制白介素-13 的产生。
Gut. 2011 Apr;60(4):449-55. doi: 10.1136/gut.2010.226860. Epub 2010 Oct 22.
6
[Possibilities and limits of immunotherapy in multiple sclerosis. Inflammatory and degenerative aspects of the disease require a new pathogenetic concept].[多发性硬化症免疫治疗的可能性与局限性。该疾病的炎症和退行性方面需要一个新的发病机制概念]
Nervenarzt. 2003 Jun;74(6):537-8; discussion 539. doi: 10.1007/s00115-003-1523-4. Epub 2003 May 14.
7
Lessons from type I interferons in ulcerative colitis.溃疡性结肠炎中I型干扰素的经验教训。
Gut. 2011 Apr;60(4):430-1. doi: 10.1136/gut.2010.229138. Epub 2011 Jan 25.
8
Multiple sclerosis--Part 2. Treatment strategies.
J Am Osteopath Assoc. 1999 Dec;99(12):611-9. doi: 10.7556/jaoa.1999.99.12.611.
9
[Disease-modifying treatments in multiple sclerosis].
Rev Prat. 1999 Nov 1;49(17):1882-9.
10
[Side-effects of the treatment with disease modifying drugs in patients with multiple sclerosis: an analysis of register data in the Yaroslavl region].[多发性硬化症患者使用疾病修饰药物治疗的副作用：对雅罗斯拉夫尔地区登记数据的分析]
Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(8):27-33.

引用本文的文献

1
Inflammatory bowel disease is associated with an increase in the incidence of multiple sclerosis: a retrospective cohort study of 24,934 patients.炎症性肠病与多发性硬化症发病率增加相关：一项对 24934 名患者的回顾性队列研究。
Eur J Med Res. 2024 Mar 20;29(1):186. doi: 10.1186/s40001-024-01776-w.
2
Adverse side effects of Glatiramer acetate and Interferon beta-1a in patients with multiple sclerosis: A systematic review of case reports.醋酸格拉替雷和干扰素β-1a治疗多发性硬化症患者的不良副作用：病例报告的系统评价
Curr J Neurol. 2023 Apr 4;22(2):115-136. doi: 10.18502/cjn.v22i2.13340.
3
Impact of Anti-CD20 therapies on the immune homeostasis of gastrointestinal mucosa and their relationship with intestinal bowel disease in multiple sclerosis: a review.
抗CD20疗法对胃肠道黏膜免疫稳态的影响及其与多发性硬化症中肠道疾病的关系：综述
Front Pharmacol. 2023 May 30;14:1186016. doi: 10.3389/fphar.2023.1186016. eCollection 2023.
4
Multiple sclerosis and inflammatory bowel disease: A systematic review and meta-analysis.多发性硬化症与炎症性肠病：系统回顾与荟萃分析。
Ann Clin Transl Neurol. 2022 Feb;9(2):132-140. doi: 10.1002/acn3.51495. Epub 2022 Jan 29.
5
Investigating the shared genetic architecture between multiple sclerosis and inflammatory bowel diseases.研究多发性硬化症和炎症性肠病之间的共享遗传结构。
Nat Commun. 2021 Sep 24;12(1):5641. doi: 10.1038/s41467-021-25768-0.
6
Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders.多发性硬化症合并自身免疫性疾病患者的治疗方法。
Ther Adv Neurol Disord. 2021 Aug 23;14:17562864211035542. doi: 10.1177/17562864211035542. eCollection 2021.
7
Stimulator of interferon genes (STING) activation exacerbates experimental colitis in mice.干扰素基因刺激物（STING）的激活会加剧小鼠实验性结肠炎。
Sci Rep. 2019 Oct 3;9(1):14281. doi: 10.1038/s41598-019-50656-5.
8
Induction or aggravation of other immune-mediated disorders by disease-modifying therapy in treatment of multiple sclerosis.在治疗多发性硬化症时，疾病修饰疗法引发或加重其他免疫介导疾病。
Iran J Neurol. 2018 Jul 6;17(3):129-136.
9
The Protective Role of Type I Interferons in the Gastrointestinal Tract.I型干扰素在胃肠道中的保护作用。
Front Immunol. 2017 Apr 6;8:410. doi: 10.3389/fimmu.2017.00410. eCollection 2017.
10
Localized delivery of interferon-β by Lactobacillus exacerbates experimental colitis.乳酸菌局部递送干扰素-β可加重实验性结肠炎。
PLoS One. 2011 Feb 18;6(2):e16967. doi: 10.1371/journal.pone.0016967.